NCT02936596

Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

Biochemical Response of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Induced by Ursodeoxycholic Acid Only or Combination Therapy of Immunosuppressive Agents

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 53 (estimated)
• Sponsor: Xiaoli Fan · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Biochemical response of primary biliary cholangitis-autoimmune hepatitis overlap syndrome induced by ursodeoxycholic acid only or combination therapy of immunosuppressive agents

Conditions

• Hepatitis, Autoimmune
• Cholangitis
• Liver Cirrhosis, Biliary
• Cholestasis

Interventions

Type	Name	Description
DRUG	Ursodeoxycholic acid combination of immunosuppressive agents	Ursodeoxycholic acid combination of immunosuppressive agents(methylprednisolone with or without azathioprine)
DRUG	Ursodeoxycholic Acid	Ursodeoxycholic Acid

Timeline

• Start date: 2016-12-01
• Primary completion: 2022-06-01
• Completion: 2022-06-01
• First posted: 2016-10-18
• Last updated: 2021-10-27

Locations

1 site across 1 country: China